Vident Investment Advisory’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-107,275	Closed	-$527K	–	896
2017 Q4	$527K	Buy	+107,275	New	+$527K	0.02%	544
2015 Q2	–	Sell	-131,891	Closed	-$1.19M	–	1067
2015 Q1	$1.19M	Buy	+131,891	New	+$1.19M	0.24%	105